Support Alert

Class 2 Medicines Recall: Lacri-Lube eye ointment

21 Sep 2015

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 medicines recall (action within 48 hours) for specific batches of Lacri-Lube Eye Ointment (Allergan Limited).  This is due to the potential for black particles, which may be introduced into the product, being present on or around the nozzle of the tube.

Further details of the recall, affected batches and for stock enquiries are available on the MHRA website.